Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK and Aspen wait for clearance from competition authority

This article was originally published in Scrip

Executive Summary

Aspen Pharmacare and GlaxoSmithKline are still waiting for approval from one more South African competition body over a deal announced earlier this year which will see GSK take a 16% stake in Africa's largest pharmaceutical manufacturer and Aspen gain the rights to distribute GSK products in the country (scripnews.com, March 25th, 2009).

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC004506

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel